The Pathophysiology, Diagnosis and Treatment of Allergic Rhinitis

被引:115
作者
Min, Yang-Gi [1 ]
机构
[1] Seoul Natl Univ, Dept Otorhinolaryngol, Coll Med, Seoul 110744, South Korea
关键词
Hypersensitivity; perennial allergic rhinitis; seasonal allergic rhinitis; physiopathology; diagnosis; therapy; AQUEOUS NASAL SPRAY; HOUSE-DUST MITES; SUBLINGUAL IMMUNOTHERAPY; DOUBLE-BLIND; BRONCHIAL HYPERRESPONSIVENESS; BECLOMETHASONE DIPROPIONATE; INTRANASAL CORTICOSTEROIDS; GROWTH SUPPRESSION; ASTHMA ARIA; CHILDREN;
D O I
10.4168/aair.2010.2.2.65
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Treatment of AR requires a stepwise approach depending on the severity and duration of symptoms. Treatment options for AR consist of allergen avoidance, pharmacotherapy, immunotherapy and surgery. For the mechanisms of AR, anti-IgE antibody and specific antibody to cytokines such as IL-4 or IL-5 that correlate with allergic inflammation have recently emerged. SLIT is currently widely used due to its efficacy, safety and convenience, which replaces subcutaneous immunotherapy. Although allergen avoidance and immunotherapy are theoretically ideal, antihistamines and intranasal corticosteroids will play the main role in the management of AR until an innovative treatment develops. However, patients' main symptom, the duration and severity of AR, patients' compliance, safety of medication and cost-effectiveness should be considered when treatment options are chosen. In conclusion, physicians should be aware of etiology, pathophysiology, symptoms, signs and diseases related to AR in order to make a correct diagnosis and choose a proper treatment option for each patient.
引用
收藏
页码:65 / 76
页数:12
相关论文
共 87 条
[1]  
Allen DB, 2002, ALLERGY ASTHMA PROC, V23, P407
[2]   The impact of atopy, sinus opacification, and nasal patency on quality of life in patients with severe nasal polyposis [J].
Alobid, I ;
Benítez, P ;
Valero, A ;
Berenguer, J ;
Bernal-Sprekelsen, M ;
Picado, C ;
Mullol, J .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2006, 134 (04) :609-612
[3]   Anaphylaxis by latex sublingual immunotherapy [J].
Antico, A. ;
Pagani, M. ;
Crema, A. .
ALLERGY, 2006, 61 (10) :1236-1237
[4]  
BANG JH, 1996, J RHINOL, V3, P130
[5]   Omalizumab-induced reductions in mast cell FcεRI expression and function [J].
Beck, LA ;
Marcotte, GV ;
MacGlashan, D ;
Togias, A ;
Saini, S .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (03) :527-530
[6]   Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine [J].
Berger, WE ;
White, MV .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 91 (02) :205-211
[7]   Allergic rhinitis in children: Diagnosis and management strategies [J].
Berger W.E. .
Pediatric Drugs, 2004, 6 (4) :233-250
[8]   Increased nasal airflow with budesonide compared with desloratadine during the allergy season [J].
Bhatia, S ;
Baroody, FM ;
deTineo, M ;
Naclerio, RM .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2005, 131 (03) :223-228
[9]   Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen) [J].
Bousquet, J. ;
Khaltaev, N. ;
Cruz, A. A. ;
Denburg, J. ;
Fokkens, W. J. ;
Togias, A. ;
Zuberbier, T. ;
Baena-Cagnani, C. E. ;
Canonica, G. W. ;
van Weel, C. ;
Agache, I. ;
Ait-Khaled, N. ;
Bachert, C. ;
Blaiss, M. S. ;
Bonini, S. ;
Boulet, L. -P. ;
Bousquet, P. -J. ;
Camargos, P. ;
Carlsen, K. -H. ;
Chen, Y. ;
Custovic, A. ;
Dahl, R. ;
Demoly, P. ;
Douagui, H. ;
Durham, S. R. ;
van Wijk, R. Gerth ;
Kalayci, O. ;
Kaliner, M. A. ;
Kim, Y. -Y. ;
Kowalski, M. L. ;
Kuna, P. ;
Le, L. T. T. ;
Lemiere, C. ;
Li, J. ;
Lockey, R. F. ;
Mavale-Manuel, S. ;
Meltzer, E. O. ;
Mohammad, Y. ;
Mullol, J. ;
Naclerio, R. ;
Hehir, R. E. O. ;
Ohta, K. ;
Ouedraogo, S. ;
Palkonen, S. ;
Papadopoulos, N. ;
Passalacqua, G. ;
Pawankar, R. ;
Popov, T. A. ;
Rabe, K. F. ;
Rosado-Pinto, J. .
ALLERGY, 2008, 63 :8-+
[10]   Characteristics of intermittent and persistent allergic rhinitis:: DREAMS study group [J].
Bousquet, J ;
Annesi-Maesano, I ;
Carat, F ;
Léger, D ;
Rugina, M ;
Pribil, C ;
El Hasnaoui, A ;
Chanal, I .
CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (06) :728-732